Transarterial radioembolization using yttrium-90 microspheres is a therapeutic option for patients with intermediate-or advanced-stage hepatocellular carcinoma, including those with recurrent or…
Ended Purchase Order Awarded Last action
- Contract number
- W81K0025PA252
- Awardee
-
Boston Scientific Corp UEI YWDHHW3DLNQ1
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $552,770
Award facts
- Contract value 100% obligated
- $552,770.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Marlborough, MA 01752, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $552,770 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a purchase order to Boston Scientific Corp for $552,770.00, effective October 1, 2025, for transarterial radioembolization using yttrium-90 microspheres as a therapeutic option for patients with intermediate- or advanced-stage hepatocellular carcinoma, including recurrent or inoperable cases. The order is firm fixed price with no set-aside. Place of performance is Marlborough, Massachusetts. Ultimate completion date is September 30, 2026.
Description
Transarterial radioembolization using yttrium-90 microspheres is a therapeutic option for patients with intermediate-or advanced-stage hepatocellular carcinoma, including those with recurrent or inoperable hepatocellular carcinoma.
Quick answers
Who was awarded contract W81K0025PA252?
W81K0025PA252 was awarded to Boston Scientific Corp by Medical Command (Department of the Army) on October 1, 2025.
How much is contract W81K0025PA252 worth?
The government has obligated $552,770 on W81K0025PA252.
Which agency awarded contract W81K0025PA252?
Medical Command (Department of the Army) awarded W81K0025PA252, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0025PA252 competed?
The extent of competition for W81K0025PA252 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award